Navigation Links
Venture Health Group Selects Planet DDS Web-based Practice Management Software
Date:11/7/2007

IRVINE, Calif., Nov. 7 /PRNewswire/ -- Is it possible to deliver high-quality dental care at affordable prices? Venture Health Group believes it is possible and is out to prove it on a large scale.

Venture Health Group (VHG), headquartered in Monterey Park, California, provides business, technology and information management support services to dentists. It is a fast-growing company with an aggressive business plan.

"Our primary focus," says Eric Kaw, CEO of VHG, "is to improve the dental health care delivery system. It's simple, really - we relieve dentists of any administrative burdens, we give them leading-edge equipment, and we use the best available information management technology to squeeze out many of the inefficiencies seen in a typical dentist office. The end result is that providers can treat their patients more effectively at affordable prices, while actually increasing their income."

But, what Kaw describes as simple has been elusive to many. "Our difference, our advantage," he continues, "is that we recognize that the newest advancements in technology, when used intelligently, can significantly increase efficiencies throughout the entire delivery system. In most dental practices, the inefficiencies created by the use of older technology cascade throughout the entire organization. It's a case of the tail wagging the dog."

VHG's choice of Planet DDS web-based software is right in line with its philosophy of using leading-edge technology to maximize effectiveness and minimize expense.

According to Richard Lee, CEO of Planet DDS, "It's a joy to work with VHG. We didn't need to show them why Internet technology is ideal for geographically dispersed dental groups. They already understood it. We started with our standard web-based practice management application, called Denticon, and modified it to meet their needs. They have some great ideas - very innovative."

Why does web-based practice management software give V
'/>"/>

SOURCE Planet DDS, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
2. NTU and Insightra Medical Inc. release their first joint venture medical device
3. Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals
4. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
5. Harmony Information Systems Raises $28 Million in Series B Financing from JMI Equity, Updata Partners, ORIX Venture Finance and Comerica Bank
6. Penn study finds pro-death proteins required to regulate healthy immune function
7. UCLA researchers identify markers that may predict diabetes in still-healthy people
8. Air pollution linked to cardiovascular risk indices in healthy young adults
9. More proof needed of safety and quality of electronic personal health records
10. Health care incentive model offers collaborative approach
11. Loneliness is bad for your health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ersity College of Medicine research team led by Ya...of regulation in the cell division cycle, which co...cer begins. , Wang, an assistant professor of bi... the findings will lead to an improved ability to ...w drugs that kill cancer cells by inhibiting cell ...
(Date:11/21/2008)...l/ -- Heska Corporation,(Nasdaq: HSKA ) today a...f,Security Analysts, 12th Annual Biotech and Spec...77 Avenue of the Americas, 2nd Floor in New York, ...5 a.m. Eastern Time (7:35 a.m.,Mountain Time) and...eks,following the presentation through a link und...
(Date:11/21/2008)...antibiotic resistance from widespread use , ... with moderate to severe chronic obstructive pulmo...uency of exacerbations through a regular, low dose...The study, published in the first issue for Decemb...tical Care Medicine , found that twice-daily 250-m...
(Date:11/21/2008)...he University of Texas M. D. Anderson Cancer Cen... to eradicate breast cancer in Panama through the ...ch of the Americas today at an event with Laura Bu...n Fernandez de Torrijos, the First Lady of Panama....ve are the U.S. Department of State and Susan G. K...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3
...he treatment of many complex problems. According t...ue of Angiology if pine bark extract Pycnogenol? (...p of muscles. The reason and scientific basis beh...act improves blood flow to the muscles which speed...
...the MCD today said there was a rise in the breedin...s it launched //a special drive to check breeding ...uito breeding, responsible for the spread of the d...arious parts of the city especially in desert cool...
...ammatory drug Dicolofenec on the country's vulture...ed to withdraw licences for manufacturing it for v...director of the prominent NGO Bombay Natural Histo...sented a copy of Drug Controller General Ashwini K...
...posed to pesticides that is used for killing bugs ...son’s disease //. Parkinson's disease is a disorde... and so may affect movement, speech and posture. ...berta Frigerio and others studied 149 patients who...
Other Medicine News:Health News:A herbal delight for athletes in solving cramp and pain problems 2Health News:A herbal delight for athletes in solving cramp and pain problems 3
(Date:11/20/2008)...SE III TRIAL SHOW SIGNIFICANT, DECREASES IN P..., IN, FIBROMYALGIA PAT...ium, Nov. 20 /PRNewswire-FirstCall/,-- Jazz Pharm...xt Brussels: UCB),announced today positive prelim...e III pivotal clinical trials of sodium oxybate (J...
(Date:11/20/2008)...Call/ -- Bionovo, Inc.,(Nasdaq: BNVI ) announce...1B,clinical trial of their lead drug candidate fo...he Society for Integrative Oncology,s Fifth Intern...any,s oral presentation was selected,as a top sco...he Best of the,SIO Session on November 20, 2008. ...
(Date:11/20/2008)...ta from a prospective,registry presented this wee...eatment with the Trellis(R) Peripheral Infusion Sy...) successfully breaks up the blood clot in most,p...ue, called isolated pharmacomechanical thrombolysi...an current catheter-directed thrombolysis,(CDT) t...
(Date:11/19/2008)...Science Corporation,researcher, Dan Tinker, prese...ual Conference in Washington, DC this week indicat...ers. The computerized brain plasticity-based,Bra...at target auditory and,language systems. The exe...ents in cognition by improving speed and accuracy ...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Using Early Stage Commercialization Activities to Build Long Term Success for the Bottom Line 8451 1Using Early Stage Commercialization Activities to Build Long Term Success for the Bottom Line 8451 2This Holiday Season Some Dream of a White Christmas The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 8449 1This Holiday Season Some Dream of a White Christmas The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 8449 2This Holiday Season Some Dream of a White Christmas The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 8449 3GeneGo Integrates With Cytoscape 2266 1GeneGo Integrates With Cytoscape 2266 2Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use 2264 1Biomerica Introduces a New 15 Minute Home Test for Allergies to Cats and Receives CE Mark Approval for Home Use 2264 2
...07 - Roche today announced,results of a small stud... treatment with Peg-Intron(R) (peginterferon alfa-... first 12 weeks, were,able to complete 12 weeks of... and ribavirin. Furthermore, 92 percent of,these p...rse of,treatment with PEGASYS. The data, which wer...
...rstCall/ -- Bristol-Myers,Squibb Company (NYSE: BM...ich showed that treatment with Baraclude (entecavi...adefovir at 48 weeks,-- a result that was also see...a from an open-label, randomized viral kinetics st...tigen (HBeAg),positive patients were presented at ...
Other Medicine Technology:Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 2Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 3Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 4Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 5Data Suggest that Pegasys May be an Option in Hepatitis C Patients,Unable to Tolerate Peg-Intron 6Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
...um Eppendorf Style Low Binding, Graduated Pipet Ti...Pipettors.Reduces DNA and protein binding. Non-rea... completely by automation. RNAse & DNAse free. AVR...nd 10 racks/cs. AVR100 is the Cell Rack packaged 9...
Packed conveniently in plastic-wrapped racks of 96 tips, Sterilized Diamond- Tips are ready to useno need to autoclave. Sterilized Diamond Tips are irradiated by gamma-rays for more efficient sterili
Like all Gilson disposable pipette tips, TowerPacks are available in a sterilized version. Each Sterilized TowerPack is individually wrapped in medical device-quality plastic to help protect tips fro
Medicine Products: